Vanguard Group Inc Cardlytics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Cardlytics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,211,595 shares of CDLX stock, worth $17.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,211,595
Previous 2,153,790
2.68%
Holding current value
$17.3 Million
Previous $19.8 Million
61.55%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CDLX
# of Institutions
165Shares Held
35.7MCall Options Held
739KPut Options Held
1.29M-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.37MShares$49.9 Million8.28% of portfolio
-
Black Rock Inc. New York, NY2.87MShares$22.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.29MShares$17.9 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2MShares$15.6 Million2.47% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$9.54 Million6.56% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $258M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...